Home
About
Pricing
Log In
Back
AKRO
Asset Logo

Akero Therapeutics, Inc. Common Stock

🇺🇸 NYSE/NASDAQ

📈 HIGH PRICE GROWTH

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 19.35%
Annual Growth

5 years average annual capital growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Akero Therapeutics, Inc. is a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including metabolic dysfunction-associated steatohepatitis (MASH). Efruxifermin (EFX), its lead product candidate for MASH, is being evaluated in three ongoing Phase 3 studies: SYNCHRONY Outcomes in patients with compensated cirrhosis (F4) due to MASH, SYNCHRONY Histology in patients with pre-cirrhotic (F2-F3 fibrosis) MASH, and SYNCHRONY Real-World in patients with MASH (F1-F4). The Phase 3 SYNCHRONY program builds on the results of two Phase 2b clinical trials, the HARMONY study in patients with pre-cirrhotic MASH and the SYMMETRY study in patients with compensated cirrhosis due to MASH. EFX is an analog of fibroblast growth factor 21 (FGF21), which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates and proteins throughout the body.

📈 Performance

Price History*

+197.62%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$53.89

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in AKRO

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

27 weeks

💵 Average investment amount

$1,688

Last time a customer invested in AKRO

8 days
AKRO investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

100%

35 - 90

🙋 Legal gender of investors

Female

100%

Male

Pearlers who invest in AKRO also invest in...

MacroGenics, Inc. Common Stock

MGNX

🙌 Performance (5Yr p.a)

-18.60%

📊 Share price

$1.65 USD
Find Out More

🙌 Performance (5Yr p.a)

125.16%

📊 Share price

$95.01 USD

🙌 Performance (5Yr p.a)

-8.25%

📊 Share price

$9.89 USD

🙌 Performance (5Yr p.a)

-18.70%

📊 Share price

$1.56 USD

🙌 Performance (5Yr p.a)

-18.13%

📊 Share price

$2.44 USD

Want more shares? Try these...

Compare
Add to watchlist